Gene therapy for surfactant protein B deficiency using recombinant AAV

Documenti analoghi

• Gene therapy for surfactant protein B deficiency using recombinant AAV vectors
  di: Meyer-Berg, H
  Pubblicazione: (2021)
• A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications
  di: Munis, AM, et al.
  Pubblicazione: (2020)
• A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications
  di: Altar M. Munis, et al.
  Pubblicazione: (2021-03-01)
• Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
  di: Meyer-Berg, H, et al.
  Pubblicazione: (2020)
• Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
  di: Helena Meyer-Berg, et al.
  Pubblicazione: (2020-10-01)